The pharmaceutical industry is preparing for the most significant expansion of government drug price regulation in decades, despite having succeeded in significantly reducing proposals from Congressional Democrats.
The House of Representatives approved approximately $ 2 trillion last week Social spending and climate bill It was endorsed by President Biden, who demanded that the government negotiate the prices of some of the older high-priced drugs covered by Medicare. The bill also limits annual drug price increases at inflation. According to the Office of Management and Budget, this measure will reduce federal drug spending and industry revenues by $ 128 billion over a decade.
Pharmaceuticals prepare for price limits on Biden’s legislative agenda
Source link Pharmaceuticals prepare for price limits on Biden’s legislative agenda